# NAC for Treating Comorbid PTSD and SUD

> **NCT02911285** · PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 90 (actual)

## Conditions studied

- Posttraumatic Stress Disorder (PTSD)
- Alcohol Use Disorder (AUD)
- Substance Use Disorder (SUD)

## Interventions

- **DRUG:** N-acetylcysteine
- **DRUG:** Placebo
- **BEHAVIORAL:** Cognitive behavioral therapy

## Key facts

- **NCT ID:** NCT02911285
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-08-05
- **Final completion:** 2019-11-04
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02911285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02911285, "NAC for Treating Comorbid PTSD and SUD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02911285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*